Head-to-head dispatch
Hims & Hers vs RestorLife Med
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.
$199/mo sema
Marked down on: Tirzepatide pricing inconsistently disclosed
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Desk Score
RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr.
$199/mo (6-month plan, compounded) sema · Verified August 1, 2026
Marked down on: The advertised $299 is a struck-through anchor price, not a starting point: the real month-to-month rate is $299, a first month runs $149 at 50% off, and the $199 rate needs six months
RestorLife Med takes this head-to-head with the higher Desk Score, 77/100 (C+) against 76/100 (C) for Hims & Hers. Hims & Hers still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Hims & Hers
76/100
C
RestorLife Med
77/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Hims & Hers | RestorLife Med |
|---|---|---|
| Semaglutide | $199/mo | $199/mo (6-month plan, compounded) |
| Tirzepatide | Not listed on Hims & Hers's site | Not listed on RestorLife Med's site (checked August 1, 2026) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want a familiar consumer-brand app experience and don't need tirzepatide. | GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support. |
| Desk Score | 76/100C | 77/100C+ |
The verdict
Desk pick — RestorLife MedRestorLife Med takes this head-to-head with the higher Desk Score, 77/100 (C+) against 76/100 (C) for Hims & Hers. Hims & Hers still holds its ground where its strengths line up with yours.
Choose Hims & Hers if…
People who want a familiar consumer-brand app experience and don't need tirzepatide.
$199/mo sema · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Choose RestorLife Med if…
GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support.
$199/mo (6-month plan, compounded) sema · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Hims & Hers · RestorLife Med.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Hims & Hers vs CoreAge Rx
- RestorLife Med vs Vaylen
- Hims & Hers vs Strut Health
- RestorLife Med vs Ondra Health
- Hims & Hers vs Invigor Medical
- RestorLife Med vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.